Overall verdict
Neutral
4.7/10
1-year performance
+39.52%
Score breakdown
Up 39.5% over 1 year, 97% of the 52-week range.
Strongest: Financial strength 6.5/10. Weakest: Growth 1.0/10.
25 analysts, target +0.0% vs the price.
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products.
It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research ; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Sector
Health Care
Industry
Life Sciences Tools and Services
Primary listing
Nyse
United States
CEO
Udit Batra
Founded
1958
Employees
7 900
Revenue / employee
400 669 USD
Next earnings
November 3, 2026 (estimated)
Institutional holders
- BlackRock, Inc.8.85%
- VANGUARD CAPITAL MANAGEMENT LLC6.69%
- VANGUARD PORTFOLIO MANAGEMENT LLC4.95%
- STATE STREET CORP4.57%
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/4.41%
- T. Rowe Price Investment Management, Inc.3.98%
- Invesco Ltd.3.65%
- ALLIANCEBERNSTEIN L.P.2.81%
- GEODE CAPITAL MANAGEMENT, LLC2.75%
- Other institutions59.05%
1179 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
436.34 USD
52-week low
282.77 USD
1-year performance
39.52%
Rising
Year-to-date performance
10.92%
Rising
Drawdown
-1.21%
Near its high
Position in the 52-week range
97% of range
Against the world ETF
Over 17 years, from September 2009 to August 2026, the share did not do better than the world ETF once risk is accounted for. It earned more, but shaking 2.2 times harder: for the risk taken, the ETF paid better.
10,000 € placed at the end of September 2009 are worth today
| Waters | 93 311 € |
| World ETF | 74 620 € |
| S&P 500 | 123 025 € |
| Risk-free placement | 11 288 € |
The risk
- Shaking:the share moves 2.2 times as much as the world ETF.
- Worst fall:-40 % between January 2025 and August 2025. 10,000 € placed at the top fell to 5 954 €. The world ETF, at worst: -34 %. The share has not returned to its high yet.
Waters earned more than the world ETF since 2009
Value of 10,000 euros placed at the end of September 2009, dividends reinvested, in euros
- Waters: 93 311 €
- World ETF: 74 620 €
- S&P 500: 123 025 €
- Risk-free placement: 11 288 €
Based on past performance. This is not a recommendation.
Gross margin 41.9%, net margin 3.6%, ROIC 1.4%, ROE 1.9%.
Net margin
3.58%
Low
Sector 5.48%|S&P 12.97%
Gross margin
41.95%
Fair
Return on equity (ROE)
1.91%
Low
Sector 3.16%|S&P 16.52%
Return on invested capital (ROIC)
1.40%
Low
Free cash flow margin (FCF)
8.08%
Fair
Profit-to-cash conversion (FCF conversion)
2.26x
Exceptional
Margin stability
6.8 pts
Uneven
Revenue to net income
Growth
1.0/10Revenue up 113.3% over 1 year, 6.0% a year over 5, EPS 5.2% a year over 5.
Revenue (trailing 12 months)
4.6Md USD
Revenue growth (1y)
113.27%
Hyper-growth
Revenue growth (3y)
6.51%
Moderate
EPS growth (1y)
-156.16%
Declining
EPS CAGR (5y)
5.19%
Low
EPS revisions (3 months)
0.46%
Revised up
Valuation
2.9/10P/E 107.6x, forward P/E 75.5x, EV/EBITDA 36.3x, PEG 20.73. The multiple sits in the 97th percentile of its own 5-year history.
P/E (TTM)
107.6x
Very expensive
Sector 50.2x|S&P 23.0x
Forward P/E
75.5x
Fair
EV / EBITDA
36.3x
Expensive
Sector 28.3x|S&P 14.5x
PEG
20.73
Very expensive
Sector 1.76|S&P 0.86
P/E vs its own 5-year history
among the 3% highest valuations
At its historical high
Market cap
41.3Md USD
Financial strength
6.5/10Cash covers 9.9% of the debt, net debt/EBITDA 0.8x.
Net debt / EBITDA
0.8x
Solid
Gearing (net debt / equity)
32.35%
Solid
Cash
539M USD
Cash / market cap
1.30%
Stretched
Cash / total debt
9.88%
Stretched
Interest coverage
2.2x
Tight
Net debt
4.9Md USD
Equity
15.2Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 430.30 USD
- MM20415.34
- MM50402.50
- MM200362.18
- RSI 1462.4
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+0.78%
200-day average slope, 3 months
+4.65%
50-day average slope, 1 month
+4.97%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
1.41 % per day
Volatility change
-35.25%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 5.71 (6) | 14.57 (25) | 6 466 (24) | 2 121 (17) | 579 (5) |
| 2027 | 11.56 (9) | 16.55 (25) | 7 134 (24) | 2 385 (17) | 1 183 (6) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 21, 2026.
Same sub-industry: 103 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 603259 | 8.0 | 8.0 | 75.1Md USD | 22.2x | 40.2 % | 47.7 % | 29.5 % | -1.7x | 2.6 % | 56.1 % | ||
| 2 | A207940 | 7.5 | 7.9 | 46.0Md USD | 31.8x | 39.9 % | 30.2 % | 16.6 % | -0.2x | 2.3 % | -13.0 % | ||
| 3 | IQV | 6.8 | 7.0 | 44.1Md USD | 33.2x | 8.1 % | 8.8 % | 6.8 % | 4.1x | 5.0 % | 47.6 % | ||
| 4 | A | 6.7 | 7.2 | 46.6Md USD | 32.5x | 19.5 % | 8.1 % | 13.9 % | 0.9x | 2.7 % | 38.1 % | ||
| 5 | DHR | 6.4 | 6.5 | 156Md USD | 39.3x | 15.9 % | 5.5 % | 5.4 % | 2.0x | 3.5 % | 18.6 % | ||
| 6 | LONN | 6.3 | 6.1 | 46.4Md USD | Not meaningful (loss) | 16.7 % | 19.2 % | 8.7 % | 1.9x | 0.6 % | 6.1 % | ||
| 7 | TMO | 6.0 | 5.9 | 246Md USD | 35.8x | 15.0 % | 10.5 % | 7.9 % | 2.8x | 3.0 % | 45.0 % | ||
| 8 | ILMN | 4.9 | 5.1 | 38.6Md USD | 47.6x | 18.4 % | 9.8 % | 18.2 % | 0.8x | 2.4 % | 175.3 % | ||
| 9 | WAT | 4.7 | 3.1 | 41.3Md USD | 107.6x | 3.6 % | 113.3 % | 1.4 % | 0.8x | 0.9 % | 39.5 % |
